These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24295625)

  • 1. Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome.
    Mogwitz S; Buse J; Ehrlich S; Roessner V
    Int Rev Neurobiol; 2013; 112():281-349. PubMed ID: 24295625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents.
    Mogwitz S; Buse J; Wolff N; Roessner V
    ACS Chem Neurosci; 2018 Apr; 9(4):651-672. PubMed ID: 29498507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].
    Müller-Vahl KR
    Nervenarzt; 2007 Mar; 78(3):264, 266-8, 270-1. PubMed ID: 16924461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.
    Budman CL
    Drugs; 2014 Jul; 74(11):1177-93. PubMed ID: 25034359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual restoring effects of gastrodin on dopamine in rat models of Tourette's syndrome.
    Zhang F; Li A
    Neurosci Lett; 2015 Feb; 588():62-6. PubMed ID: 25549540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time estimation in a case of Tourette's syndrome: Effect of antipsychotic medications.
    Inagawa T; Ueda N; Nakagome K; Sumiyoshi T
    Neuropsychopharmacol Rep; 2020 Jun; 40(2):198-200. PubMed ID: 32174031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological options for the treatment of Tourette's disorder.
    Jiménez-Jiménez FJ; García-Ruiz PJ
    Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models.
    Lv H; Li A; Ma H; Liu F; Xu H
    J Ethnopharmacol; 2009 Jul; 124(3):488-92. PubMed ID: 19467315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of Tourette's syndrome: current opinions.
    Müller-Vahl KR
    Expert Opin Pharmacother; 2002 Jul; 3(7):899-914. PubMed ID: 12083990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis.
    Nomura Y; Segawa M
    Brain Dev; 2003 Dec; 25 Suppl 1():S37-42. PubMed ID: 14980371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tourette syndrome: clinical characteristics and current management strategies.
    Kossoff EH; Singer HS
    Paediatr Drugs; 2001; 3(5):355-63. PubMed ID: 11393328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromodulation in Tourette syndrome: dopamine and beyond.
    Buse J; Schoenefeld K; Münchau A; Roessner V
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1069-84. PubMed ID: 23085211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual regulating effect of Ningdong granule on extracellular dopamine content of two kinds of Tourette's syndrome rat models.
    Zhao L; Qi F; Zhang F; Wang Z; Mu L; Wang Y; En Q; Li J; Du Y; Li A
    Biosci Trends; 2015 Aug; 9(4):245-51. PubMed ID: 26248644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
    Peterson BS
    J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual regulating effects of gastrodin on extracellular dopamine concentration in rats models of Tourette's syndrome.
    Zhang F; Li A
    Int J Neurosci; 2015; 125(10):784-92. PubMed ID: 25271797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement.
    Devinsky O
    Arch Neurol; 1983 Aug; 40(8):508-14. PubMed ID: 6347142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.